CIPLA LIMITED FDA Approval ANDA 091203

ANDA 091203

CIPLA LIMITED

FDA Drug Application

Application #091203

Documents

Letter2012-07-05

Application Sponsors

ANDA 091203CIPLA LIMITED

Marketing Status

None (Tentative Approval)001

Application Products

001SOLUTION; ORAL80MG; 20MG0LOPINAVIR; RITONAVIRLOPINAVIR; RITONAVIR

FDA Submissions

ORIG1TA2012-06-29

Submissions Property Types

ORIG1Null0

CDER Filings

CIPLA LIMITED
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91203
            [companyName] => CIPLA LIMITED
            [docInserts] => ["",""]
            [products] => [{"drugName":"LOPINAVIR; RITONAVIR","activeIngredients":"LOPINAVIR; RITONAVIR","strength":"80MG; 20MG","dosageForm":"SOLUTION; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LOPINAVIR; RITONAVIR","submission":"LOPINAVIR; RITONAVIR","actionType":"80MG; 20MG","submissionClassification":"SOLUTION; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.